|
Volumn 112, Issue 5, 1996, Pages 1372-1377
|
Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
DNA FRAGMENT;
PROTEIN P53;
ADENOVIRUS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CELL PROLIFERATION;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG THERAPY;
ETIOLOGY;
GENE THERAPY;
GENE TRANSFER;
HUMAN;
HUMAN CELL;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRATUMORAL DRUG ADMINISTRATION;
LUNG CANCER;
MOUSE;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SUBCUTANEOUS TISSUE TUMOR;
VIRUS RECOMBINANT;
|
EID: 0029835487
PISSN: 00225223
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5223(96)70154-X Document Type: Article |
Times cited : (141)
|
References (7)
|